Archive for October 2024
Journal of Clinical Medicine Publication Demonstrates Clinical Utility of SeptiCyte® RAPID in Critically Ill Heterogeneous Patient Populations
SeptiCyte® RAPID demonstrated consistent performance in discriminating sepsis from Systemic Inflammatory Response Syndrome (SIRS) regardless of demographics or the presence or absence of medical conditions SEATTLE and BRISBANE, Australia, Oct. 16, 2024 /PRNewswire/ — Immunexpress, Pty Ltd., a molecular diagnostics company focused on improving outcomes for suspected sepsis patients, today announced the publication of a study in the Journal of…
Read MoreRapid and Robust Identification of Sepsis Using SeptiCyte RAPID in a Heterogeneous Patient Population
From the Journal of Clinical Medicine We are pleased to inform you that your article “Rapid and Robust Identification of Sepsis Using SeptiCyte RAPID in a Heterogeneous Patient Population” has been published in JCM as part of the Special Issue Sepsis and Organ Dysfunction: New Insights into Diagnosis and Treatment and is available online at…
Read More